(Q37476452)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19429859%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

review article

1 reference

title

The epidermal growth factor receptor: a link between inflammation and liver cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19429859%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19429859%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Maria Ujue Latasa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19429859%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Saioa Goñi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19429859%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Matias Avila

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19429859%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

Maria J Perugorria

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19429859%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Josefa Castillo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19429859%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Mónica Santamaría

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19429859%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Jesús Prieto

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19429859%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

8 May 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19429859%20AND%20SRC:MED&resulttype=core&format=json

Experimental Biology and Medicine

27 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19429859%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

234

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19429859%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19429859%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

713-725

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19429859%20AND%20SRC:MED&resulttype=core&format=json

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

27 January 2020

cites work

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Hepatocellular carcinoma: epidemiology, risk factors, and screening

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Viral hepatitis and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Hepatitis B virus-induced oncogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Viral hepatitis and liver cancer: the case of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Molecular mechanisms of alcohol-mediated carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Genetics of hepatocellular tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Dysregulation of growth factor signaling in human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Resolving fibrosis in the diseased liver: translating the scientific promise to the clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Hepatocellular carcinoma pathogenesis: from genes to environment

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

New therapies for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

The role of cytokines in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Comparative and integrative functional genomics of HCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Mechanisms of hepatic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Liver fibrosis: cellular mechanisms of progression and resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Toll-like receptors and adaptor molecules in liver disease: update

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Emerging paradigm: toll-like receptor 4-sentinel for the detection of tissue damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Identification of a key pathway required for the sterile inflammatory response triggered by dying cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Mammalian toll-like receptors: from endogenous ligands to tissue regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Impaired hepatocyte regeneration in toll-like receptor 4 mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

NF-kappaB and cancer-identifying targets and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Multiple G-protein-coupled receptor signals converge on the epidermal growth factor receptor to promote migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Survival and apoptosis: a dysregulated balance in liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Mitogenic signaling pathways induced by G protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Cyclooxygenase-2 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Role of Toll-like receptors in gastrointestinal malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR family

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Membrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Epidermal growth factor receptor: mechanisms of activation and signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Tackling EGFR signaling with TACE antagonists: a rational target for metalloprotease inhibitors in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

EGFR signal transactivation in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Cyclooxygenase-2 transactivates the epidermal growth factor receptor through specific E-prostanoid receptors and tumor necrosis factor-alpha converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Cyclooxygenase-2-derived prostaglandin E2 stimulates Id-1 transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

The epidermal growth factor receptor system in skin repair and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Fas ligand-induced proinflammatory transcriptional responses in reconstructed human epidermis. Recruitment of the epidermal growth factor receptor and activation of MAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Multiple TLRs activate EGFR via a signaling cascade to produce innate immune responses in airway epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Epidermal growth factor receptor signaling to Erk1/2 and STATs control the intensity of the epithelial inflammatory responses to rhinovirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

DNA vector augments inflammation in epithelial cells via EGFR-dependent regulation of TLR4 and TLR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

EGFR signaling is required for TGF-beta 1 mediated COX-2 induction in human bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

The mechanism of cleavage of EGFR ligands induced by inflammatory cytokines in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Src and ADAM-17-mediated shedding of transforming growth factor-alpha is a mechanism of acute resistance to TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Macrophage-inflammatory protein-3alpha mediates epidermal growth factor receptor transactivation and ERK1/2 MAPK signaling in Caco-2 colonic epithelial cells via metalloproteinase-dependent release of amphiregulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

TACE/ADAM-17: a component of the epidermal growth factor receptor axis and a promising therapeutic target in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

The EGF receptor is required for efficient liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Expression of tumor necrosis factor-alpha converting enzyme in liver regeneration after partial hepatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Liver regeneration and hepatocarcinogenesis in transforming growth factor-alpha-targeted mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Epiregulin is not essential for development of intestinal tumors but is required for protection from intestinal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Heparin-binding epidermal growth factor-like growth factor links hepatocyte priming with cell cycle progression during liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Amphiregulin: an early trigger of liver regeneration in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Novel role for amphiregulin in protection from liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go?

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

TNF-alpha regulates transforming growth factor-alpha expression in regenerating murine liver and isolated hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

HB-EGF is a paracrine growth stimulator for early tumor prestages in inflammation-associated hepatocarcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

CD95 ligand is a proliferative and antiapoptotic signal in quiescent hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Macrophage activation increases the invasive properties of hepatoma cells by destabilization of the adherens junction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

ADAM17 mRNA expression and pathological features of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Inhibition of the EGF receptor blocks autocrine growth and increases the cytotoxic effects of doxorubicin in rat hepatoma cells: role of reactive oxygen species production and glutathione depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Activation of NADPH oxidase by transforming growth factor-beta in hepatocytes mediates up-regulation of epidermal growth factor receptor ligands through a nuclear factor-kappaB-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Involvement of EGF receptor and c-Src in the survival signals induced by TGF-beta1 in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Transforming growth factor beta engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Selective inhibition of TNF-alpha-induced activation of mitogen-activated protein kinases and metastatic activities by gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin alphav-mediated ADAM activity in hepatocellular carcinoma: a novel functional target for gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Epidermal growth factor receptor transactivation mediates tumor necrosis factor-induced hepatocyte replication

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

EGFR antagonists in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

EGFR-targeted therapeutics: focus on SCCHN and NSCLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Erlotinib in previously treated non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Erlotinib in non-small cell lung cancer treatment: current status and future development

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Mutations in the epidermal growth factor receptor gene and effects of EGFR-tyrosine kinase inhibitors on lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Increases of amphiregulin and transforming growth factor-alpha in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Clinical significance of pretreatment serum amphiregulin and transforming growth factor-alpha, and an epidermal growth factor receptor somatic mutation in patients with advanced non-squamous, non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

EGFR and VEGFR as potential target for biological therapies in HCC cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five-year follow-up of Southwest Oncology Group Protocol S9911.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Molecular targeted therapies in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Absence of epidermal growth factor receptor exon 18-21 mutation in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

Pivotal role of mTOR signaling in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12

The EGF receptor family: spearheading a merger of signaling and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0901-MR-12